Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George W Booz

Showing results (81-90 of 181) with videos related to

Pageof 19
Sort By:
Frontiers in Physiology|March 6, 2018
Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic StrategiesWenshan Lv, George W Booz, Fan Fan, et al.
Molecular and Cellular Biochemistry|December 19, 2002
Cytokine G-protein signaling crosstalk in cardiomyocytes: attenuation of Jak-STAT activation by endothelin-1George W Booz, Jonathan N E Day, Robert Speth, et al.
Frontiers in Physiology|July 26, 2021
Atrial Natriuretic Peptide<sub>31-67</sub>: A Novel Therapeutic Factor for Cardiovascular DiseasesGustavo Jose Justo da Silva, Raffaele Altara, George W Booz, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 7, 2011
Calyculin A reveals serine/threonine phosphatase protein phosphatase 1 as a regulatory nodal point in canonical signal transducer and activator of transcription 3 signaling of human microvascular endothelial cellsCarlos Zgheib, Fouad A Zouein, Rony Chidiac, et al.
European Journal of Pharmacology|December 13, 2017
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targetsWenshan Lv, George W Booz, Yangang Wang, et al.
Journal of Cardiovascular Pharmacology|August 23, 2022
Colchicine and Acute Coronary Syndromes: A New Trick for an Old Drug?Ghadir Amin, Gaelle Massoud, Souha Fares, et al.
Journal of Cardiovascular Pharmacology|July 18, 2025
Phthalates and Cardiovascular Risk: A Call for Awareness in Clinical PracticeGiuseppe Biondi-Zoccai, Vassilios S Vassiliou, Maria Camilla Palumbo, et al.
Frontiers in Pharmacology|December 1, 2016
Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in HypertensionRaffaele Altara, Romain Harmancey, Sean P Didion, et al.
European Journal of Pharmacology|June 11, 2018
Conflicting roles of 20-HETE in hypertension and renal end organ damageChao Zhang, George W Booz, Qing Yu, et al.
Journal of Cellular and Molecular Medicine|March 18, 2015
High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 lossHeng Zeng, Venkata Ramana Vaka, Xiaochen He, et al.
Pageof 19

Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Frontiers in Physiology|March 6, 2018
Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic StrategiesWenshan Lv, George W Booz, Fan Fan, et al.
Molecular and Cellular Biochemistry|December 19, 2002
Cytokine G-protein signaling crosstalk in cardiomyocytes: attenuation of Jak-STAT activation by endothelin-1George W Booz, Jonathan N E Day, Robert Speth, et al.
Frontiers in Physiology|July 26, 2021
Atrial Natriuretic Peptide<sub>31-67</sub>: A Novel Therapeutic Factor for Cardiovascular DiseasesGustavo Jose Justo da Silva, Raffaele Altara, George W Booz, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 7, 2011
Calyculin A reveals serine/threonine phosphatase protein phosphatase 1 as a regulatory nodal point in canonical signal transducer and activator of transcription 3 signaling of human microvascular endothelial cellsCarlos Zgheib, Fouad A Zouein, Rony Chidiac, et al.
European Journal of Pharmacology|December 13, 2017
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targetsWenshan Lv, George W Booz, Yangang Wang, et al.
Journal of Cardiovascular Pharmacology|August 23, 2022
Colchicine and Acute Coronary Syndromes: A New Trick for an Old Drug?Ghadir Amin, Gaelle Massoud, Souha Fares, et al.
Journal of Cardiovascular Pharmacology|July 18, 2025
Phthalates and Cardiovascular Risk: A Call for Awareness in Clinical PracticeGiuseppe Biondi-Zoccai, Vassilios S Vassiliou, Maria Camilla Palumbo, et al.
Frontiers in Pharmacology|December 1, 2016
Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in HypertensionRaffaele Altara, Romain Harmancey, Sean P Didion, et al.
European Journal of Pharmacology|June 11, 2018
Conflicting roles of 20-HETE in hypertension and renal end organ damageChao Zhang, George W Booz, Qing Yu, et al.
Journal of Cellular and Molecular Medicine|March 18, 2015
High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 lossHeng Zeng, Venkata Ramana Vaka, Xiaochen He, et al.
Pageof 19